NICB International Conference on Global mRNA and Protein Expression Analysis
Friday 8 September 2006

Back row from left. Prof. Denis Slamon, Prof John Crown, Prof. Martin Clynes, Dr. Donnacha O'Driscoll, Dr. Robert O'Connor. Front from left Ms. Brigid Browne, Dr. Norma O'Donovan, Dr. Susan Kennedy, Dr. Winfried Albert and Dr. Michael Moriarty.

DCU’s National Institute for Cellular Biotechnology hosted a two-day International Conference on the use of new global approaches to understanding and eventually treating diseases such as breast cancer, prostate cancer and brain cancer.

World-renowned experts addressed the conference, including representatives from science, industry and medicine. This integrated approach is fundamental to the development of cancer research.

Interesting talks include:

• Growth factor receptors as cancer therapeutic targets- John Crowne, Dublin
• EGFR and HER-2 antagonists in breast cancer therapy- Norma O’ Donovan, Dublin
• New approaches to treatment of brain cancer- Rolf Bjerkvig, Bergen
• Clinical Applications of expression profiling and proteomics in prostate cancer- John Masters, London
• Proteomic analysis of 5- Fluorouracil’s anti- proliferative effect on normal and cancer epithelial cells of the lung- William Bryan, DCU
• Ethical issues in biotechnology- Donal O’ Mathuna, Dublin
• Detection an molecular profiling of circulating tumour cells- Winifred Albert, Lagenhagen
• Advances in treatment of opportunistic fungal infections in cancer patients- Kevin Kavanagh, Maynooth
• Inhibiting efflux pumps that mediate cancer drug resistance – pharmacology and pharmacokinetics- Robert O’ Connor, DCU
• Repair of ocular damage- the need for stem cell therapy- William Power/ Andra Bobart, Dublin